Colorectal cancer studies
Colorectal cancer clinical trials start with a conversation
Colorectal Cancer Clinical Trials shows you which studies are recruiting and puts you in touch with a study team. The studies themselves examine investigational medications, surgical and radiation approaches, and screening methods for cancers of the colon and rectum. Your first step is a short conversation. It costs nothing, and it does not obligate you to anything.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Colorectal cancer studies in numbers
- colorectal cancer studies recruiting in the U.S.
- 525
- states with a study site
- 51
- cities with a study site
- 1,173
- studies that accept healthy volunteers
- 64
Source: ClinicalTrials.gov. Data processed .
Find colorectal cancer studies near you
These states have the most studies recruiting right now.
Texas
195 studies recruiting.
California
193 studies recruiting.
New York
151 studies recruiting.
Florida
132 studies recruiting.
Virginia
98 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Colorectal cancer studies recruiting now
As of November 16, 2026, 525 colorectal cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This is what they have in common.
What they test
- medications287
- other approaches95
- procedures83
- behavioral approaches such as talk therapy or training57
- biologics such as vaccines or antibodies44
A study can test more than one.
Main purpose
- treating a condition310
- supportive care31
- prevention21
- screening21
Phase
- Early Phase 18
- Phase 1109
- Phase 1/282
- Phase 290
- Phase 2/34
- Phase 321
- Phase 44
- No phase109
- Observational98
Studies of devices and behavioral approaches have no phase.
Who runs them
- university, hospital or other294
- industry208
- government23
Who they enroll
- adults (18 to 64)520
- older adults (65 and over)511
- children (under 18)18
64 also accept healthy volunteers.
Where: sites in 51 states. The cities with the most are Houston, TX (140), New York, NY (120), Los Angeles, CA (92), Boston, MA (86), Nashville, TN (78), St Louis, MO (63), Fairfax, VA (62), Chicago, IL (53).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 525 studies.
Recently updated colorectal cancer studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Allentown, PA · Ann Arbor, MI · Atlanta, GA · and 42 more U.S. locations
- Registry record
- NCT05863195 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Recruiting in
- Boston, MA · Cerritos, CA · Fairfax, VA · and 17 more U.S. locations
- Registry record
- NCT06324357 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Recruiting in
- Fairfax, VA · Houston, TX · San Antonio, TX
- Registry record
- NCT06385925 · updated
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 to 99
- All sexes
- Sponsor
- Erasca, Inc.
- Recruiting in
- Atlanta, GA · Aurora, CO · Boston, MA · and 7 more U.S. locations
- Registry record
- NCT06983743 · updated
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Recruiting in
- Aurora, CO · Canton, OH · Detroit, MI · and 1 more U.S. location
- Registry record
- NCT07213609 · updated
Decision Counseling and Follow-up for Shield+ Patients
- Observational
- Ages 45 to 75
- All sexes
- Sponsor
- Guardant Health, Inc.
- Recruiting in
- Philadelphia, PA
- Registry record
- NCT07620535 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in the United States on ClinicalTrials.gov.
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which colorectal cancer studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
What colorectal cancer studies look at
Colorectal cancer clinical trials test investigational medications, surgical and radiation approaches, and screening methods for cancers of the colon and rectum. No two trials ask the same thing of you. A single question sits at the center of every trial, and what you are asked to do follows from that question.
Treat everything under study as investigational. Researchers have not finished learning how well it works or what risks it carries, and filling that gap is why the trial is running.
Who may be able to take part
Requirements are set study by study. A colorectal cancer trial may look at how old you are, your medical background, any medications you are on today, and the way the condition affects you. People without the condition are enrolled in some studies too.
Leave the eligibility question to the study team. They check it with you at a screening visit, so you never have to figure it out alone. See how eligibility and screening work.
How taking part works
You go through four steps, and moving on from any of them is your decision.
Tell us what you are looking for
Pick up the phone or fill in a short form. Let us know the condition you are looking into, or the kind of study you have in mind.
Talk with a coordinator
You hear from a coordinator, who tells you in plain language which studies may be a match and answers your questions.
Meet the study team
Continuing is your call. Say yes, and the study team goes over the colorectal cancer trial with you in detail, then screens you to see whether you are eligible.
Decide what is right for you
The choice to join stays with you from start to finish. You are free to walk away from a study whenever you like, whatever your reason, even after you have said yes.
Why people take part in colorectal cancer studies
Your reason for joining a research study may not be the same as someone else's. Whatever it is, it is a good one, and it is worth talking through before you decide.
- You want a research team to follow your health closely while the study runs.
- You want to learn more about a condition you live with.
- You want to help answer research questions that may shape how other people are cared for in the future.
Keep in mind that a study is research. It is not treatment, and nobody can promise that taking part will help you personally. For a plain explanation, read what a clinical trial is.
Your safety and your rights come first
No colorectal cancer study can enroll a single person until an independent ethics committee has reviewed it. The details reach you in writing first, and only then are you asked to agree. Read up on what informed consent involves, the way each study is reviewed and monitored, and the rights you keep the whole way through.
Common questions about colorectal cancer studies
Do I need a diagnosis to join a study about colorectal cancer?
The answer changes with each study. In certain ones a diagnosis must already be confirmed. In the rest, assessment is part of screening. What applies to you is something the study team will spell out.
Would I have to change the care I receive now?
Nothing about your care should change on your decision alone. Certain studies let you carry on with the care you already have, and certain ones rule it out. Expect the study doctor to review the question with you. You can also discuss it with your own doctor before you decide.
Is there a cost to take part?
Generally, participants are not charged for the study medication, the study tests, or the visits a study requires. See how costs are handled.
Does it cost anything to ask about a study?
No. You pay nothing to talk with Colorectal Cancer Clinical Trials, and you are not signed up for anything by asking questions.
Do I have to take part if I call?
No. At every step, continuing is your decision. You can stop whenever you choose.
Who decides whether I can join a study?
The study team decides, once you have had a screening visit. Requirements are different for each study. Read how screening works.
Ask about colorectal cancer studies
Asking ties you to nothing. Pass along a few details, and a coordinator will reach out to you.
Learn more from independent sources
- Colorectal Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)